Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Gabelli: Teva Pharmaceutical (NYSE:TEVA) set to rebound from the lowest valuations among peers
Gabelli: Teva Pharmaceutical (NYSE:TEVA) set to rebound from the lowest valuations among peers
Gabelli: Teva Pharmaceutical (NYSE:TEVA) set to rebound from the lowest valuations among peers
Submitted by
admin
on December 29, 2012 - 10:32am
Source:
The Point Daily
News Tags:
Teva
Headline:
Gabelli: Teva Pharmaceutical (NYSE:TEVA) set to rebound from the lowest valuations among peers
Do Not Allow Advertisers to Use My Personal information
